Vai al contenuto principale della pagina

Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies Visualizza cluster
Pubblicazione: Washington, District of Columbia : , : National Academies Press, , [2012]
©2012
Descrizione fisica: 1 online resource (132 p.)
Disciplina: 615.1/9
Soggetto topico: Drug monitoring
Drug development - United States
Drugs - United States - Design
Pharmaceutical industry - United States - Quality control
Soggetto genere / forma: Electronic books.
Persona (resp. second.): OlsonSteve <1956->
ClaiborneAnne B.
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references (pages 71).
Nota di contenuto: Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
Sommario/riassunto: Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
Titolo autorizzato: Maximizing the impact of the Cures Acceleration Network  Visualizza cluster
ISBN: 0-309-26117-1
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910463950903321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui